Advertisement

Anxiety in Autism Spectrum Disorder

Anxiety in Autism Spectrum Disorder

Eric Hollander, MD

Eric Hollander

Dr. Eric Hollander is the Director of Spectrum Neuroscience, as well as a Clinical Professor of Psychiatry and Behavioral Sciences at the Albert Einstein College of Medicine and Director of the Autism and Obsessive Compulsive Spectrum Program at Montefiore Medical Center and the Albert Einstein College of Medicine. Dr. Hollander has published more than 500 scientific publications in the professional literature. Dr. Hollander is listed for the past ten years in NY Magazine’s and Castle Connolly’s “Best Doctors”, and “Best Doctors in America”.

The Autism and Obsessive Compulsive Spectrum Program and the Anxiety and Depression Program at the Albert Einstein College of Medicine and Montefiore Medical Center : 
https://www.einstein.yu.edu/departments/psychiatry-behavioral-sciences/autism-program/

Spectrum Neuroscience and Treatment Institute:
http://www.spectrumneuroscience.com/

Last publication for APPI
https://www.appi.org/Autism_Spectrum_Disorders

Elisabetta Burchi, MD

Burchi

Dr. Elisabetta Burchi is resident in psychiatry at the University of Florence (Italy) and research fellow at the Autism and Obsessive Compulsive Spectrum Program at Montefiore Medical Center and the Albert Einstein College of Medicine. 

 

Anxiety in Autism Spectrum Disorder

Share
No

The Autism and Obsessive Compulsive Spectrum Program and the Anxiety and Depression Program at the Albert Einstein College of Medicine and Montefiore Medical Center : 
https://www.einstein.yu.edu/departments/psychiatry-behavioral-sciences/autism-program/

Spectrum Neuroscience and Treatment Institute:
http://www.spectrumneuroscience.com/

Last publication for APPI
https://www.appi.org/Autism_Spectrum_Disorders

Introduction

In recent history, autism has been identified in several gifted artists and scientists, although it is more generally associated with severe and impairing conditions. Today, we talk about “autism spectrum disorder” (ASD), a definition that recognizes the heterogeneity and complexity of a lifelong condition, whose symptoms fall into a continuum and account for large variations from patient to patient. A number of medical and psychiatric comorbidities ranging from gastro-intestinal and autoimmune disorders, to ADHD, depression, OCD and anxiety disorders, contribute to challenges in assessment and treatment of this condition, which requires a multidisciplinary approach. 

Although anxiety is not considered a core feature of ASD, anxiety disorders are the most common comorbid conditions in these patients. Because of the great impact on the course of the disorder, recognizing anxiety and treating it properly is particularly important for the well-being of these patients. 

Core Aspects Of ASD And Their Clinical Presentation

As the Diagnostic and Statistical Manual of Mental Disorders- 5th edition states, the core symptom domains of ASD are constituted by deficits in social communication across multiple contexts (deficits in social-emotional reciprocity, non-verbal communication and developing relationships), as well as restricted, repetitive patterns of behavior and interests. 
These symptoms must be present in the early developmental period, however they may not become apparent until later in life.

  • Deficits in social communication 
    • Atypical or absent eye contact is one of the first symptom observed in early childhood. Facial expressions may be difficult to read; vocal characteristics also appear to be atypical, such as monotonous, flat, exaggerated or inappropriate voice; atypical gestures may also be present, with a lack of pointing to orient other’s attention.  On the other hand, these children have troubles in reading facial expressions, gestures, and emotions in others; these difficulties along with language delays promote consequent difficulties in social interactions. 
  • Repetitive patterns of behavior, restricted interests and resistance to change 
    • Children with ASD typically present with lack of interest in others, showing preference for objects that may be used in a nonplay stereotyped manner or for self stimulation, sometimes linked to unusual response to sights, sounds, smells or textures. Rigidity may encompass ritualistic habits (eg eating the same food everyday) and restricting interests, defined as unusually intense interest with an object or a topic that usually lead to activities with no functionality (eg because of a preoccupation with cars, memorizing all makes and models). Resistance to change is usually expressed with any deviance to routine (for example, during travel routes, if a detour is taken, children can act out with tantrum and self-injury).

When Do These Patients Seek Help?

The main reasons why patients with ASD seek help can be divided into two categories, reflecting two different subgroups of the disorder: 

  • behavioral issues, such as aggression, irritability, self-injurious behaviors,  linked to the core aspect of repetitive behaviors and compulsivity; these issues especially concern the subgroup with intellectual disabilities and language difficulties.
  • internalizing symptoms, such as depression and anxiety, that patients with ASD, especially those with “high functioning autism” may develop as a result of their insight but continued lack of social communication skills

Is Anxiety An Important Problem In Autism?
Although anxiety is not considered a core feature of ASD, 40% of young people with ASD have clinically elevated levels of anxiety or at least one anxiety disorder, including obsessive compulsive disorder. 
It is particularly important to recognize and treat anxiety in ASD since it has a great impact on the course and the core aspects of the disorder, exacerbating social withdrawal as well as repetitive behaviors. 
Moreover, while untreated comorbid anxiety has been associated with the development of depression, aggression, and self-injury in ASD, an early recognition and treatment may convey better prognosis for these patients. 

How Anxiety Arises In ASD And How To Recognize It
It’s not easy to recognize the presence of anxiety in patients with ASD, because of overlapping symptomatology and altered presentations of symptoms. 
Patients who are minimally verbal may be unable to report their internal states (eg worry) and instead demonstrate anxiety through disruptive behaviors, while others may be verbally fluent but present with difficulties in understanding ones’ own emotions and expressing these emotions. 

Typically, anxiety may present with different features at different times in the course of ASD and in association with different demands from environment:

  • Specific phobia: a specific phobia, namely an intense, irrational fear of something that poses little or no actual danger, may arise early in the course of ASD because of over responsiveness to sensory stimulation, such as a loud environment; specific phobias in these patients usually involve highly unusual stimuli  (eg advertisement jingles, balloons popping, vacuum cleaners, toilet flushing, alarms at school..), but may also present fears (eg of the dark, insects, needles) that are typical of developing youth.
  • Obsessive compulsive disorder:  characterized by unwanted and intrusive thoughts and consequent compulsive behaviors, OCD is often comorbid with ASD; identifying comorbid OCD in these patients is important because while the engagement in repetitive behaviors which is typical of ASD is unrelated to distress, compulsions are performed as a coping mechanism to relieve anxiety.
  • Social anxiety: as the patient ages and the environment becomes more demanding, social communication impairment may underline the development of social anxiety, especially if the patient is high functioning and aware of his/her social incompetence. Social anxiety, defined as intense anxiety or fear of being negatively evaluated in a social or performance situation, in turn leads to avoidance of social situations, therefore limiting the patient’s opportunities to practice social skills, and may predispose the individual to negative reactions from peers and even bullying. 
  • Separation anxiety: social impairment may evoke overprotective reactions from parents that in turn may strengthen avoidance behavior in the child; separation anxiety may then arise when the patient has to separate from attachment figures, for example at the moment of leaving the family for college.
  •  Other atypical symptoms of anxiety: youth with ASD often experience symptoms of anxiety that not necessarily fit within a diagnosis, for example intense levels of distress related to changes in their routine or environment.


How To Treat Anxiety In ASD. A Personalized Approach 

The evidence concerning the impact of anxiety on the course of ASD highlight the importance of treating anxiety problems in a timely fashion to improve overall functioning of individuals with ASD. 
While not a core aspect of ASD, but rather a distinct disorder arising in the course of ASD, anxiety can be treated separately from the other domains of the disorder, but treatments have to be adapted to this population. 
Specific approach for the treatment of anxiety in this population include:

  • Pharmacological treatment for anxiety in ASD
    • Although selective serotonin reuptake inhibitors (SSRIs) are considered the first line of pharmacological treatment for anxiety disorders and OCD in the general population, research examening their use in ASD is limited and controversial, with modest efficacy and high rates of negative effects. Our studies on Fluoxetine in adults and children with ASD showed improvement in repetitive behaviors, however a large controlled trial showed that Citalopram doesn’t differ from placebo in reducing repetitive behaviors and that some patients have negative behavioral effects, such as hyperactivity, impulsivity and insomnia. ASD patients may be sensitive to low doses of drugs and present considerable variations in treatment responses and adverse events to medications. Our group has seen that a genetic variant can be associated with adverse events to SSRIs in these patient. There is limited evidence to support the use of Buspiron for anxiety in autism.  
  • Psychotherapy and social skills interventions for anxiety in ASD
    • Cognitive behavioral therapy (CBT) has demonstrated robust efficacy for treating anxiety disorders and OCD in youth with ASD, especially in those with high functioning and adequate verbal skills. The core treatments components of CBT for anxiety involve: 
      • psychoeducation about anxiety (eg learn to differentiate between helpful and unhelpful anxiety, identify physiological components of anxiety)
      • cognitive strategies (eg learn to identify anxious cognitions and improve executive functions and flexibility) 
      • behavioral strategies (eg graded exposure to feared stimuli) 
      • interventions with parents: psychoeducation and parent-meditated interventions for core symptoms (eg building helpful parenting responses to anxious behaviors and assisting the child to implement techniques outside the session) and maladaptive behaviors (eg changing maladapting behaviors in parenting style, such as over protection that limit the child’s independent daily skills). 
    • Just as ASD patients need personalized use of medications, psychological interventions should be adapted to the characteristics of these patients to be fully effective.
    • Clinicians should integrate standard CBT with approaches that focus on the core characteristics of autism that can mediate the development of anxiety or also limit the effectiveness of standard approach:
      • emotional literacy and mindfulness-based approach may be helpful to improve those emotional recognition skills that are required to consequently tolerate the experience of aversive emotions and respond flexibly to stressors; 
      • social skills interventions, such as in vivo practice of reciprocity skills, in order to improve engagement with others and emotional responses;
      • make large use of concrete examples, visual prompts and also virtual reality environment to help the patient to cope with difficulties in abstract thinking.
  • New investigational approaches:  our research group is currently conducting clinical trials investigating oxytocin, vasopressin receptor 1A antagonists and cannabinoids (CBDV) as treatments to specifically target the mechanisms thought to be involved in the core aspects fo ASD, namely social communication and repetitive behaviors, which are also linked to anxiety. Further research is needed.

Take Home Messages

  • There are many treatments for ASD patients, such as pharmacotherapy, psychotherapy, educational therapy, occupational therapy, physical therapy and family interventions.
  • These patients need a personalized and multimodal assessment and treatment. 
  • Consideration of co-occurring conditions is particularly important in designing interventions that improve overall functioning. 
  • Anxiety should never be neglected in ASD and may be treated as a separate diagnosis, but therapy should be adapted for these patients.
  • Early intervention programs for infants with or at-risk for ASD with the goal of facilitating skills to improve coping and resilience, may prevent the escalation of anxiety symptoms.

Eric Hollander, MD

Eric Hollander

Dr. Eric Hollander is the Director of Spectrum Neuroscience, as well as a Clinical Professor of Psychiatry and Behavioral Sciences at the Albert Einstein College of Medicine and Director of the Autism and Obsessive Compulsive Spectrum Program at Montefiore Medical Center and the Albert Einstein College of Medicine. Dr. Hollander has published more than 500 scientific publications in the professional literature. Dr. Hollander is listed for the past ten years in NY Magazine’s and Castle Connolly’s “Best Doctors”, and “Best Doctors in America”.

The Autism and Obsessive Compulsive Spectrum Program and the Anxiety and Depression Program at the Albert Einstein College of Medicine and Montefiore Medical Center : 
https://www.einstein.yu.edu/departments/psychiatry-behavioral-sciences/autism-program/

Spectrum Neuroscience and Treatment Institute:
http://www.spectrumneuroscience.com/

Last publication for APPI
https://www.appi.org/Autism_Spectrum_Disorders

Elisabetta Burchi, MD

Burchi

Dr. Elisabetta Burchi is resident in psychiatry at the University of Florence (Italy) and research fellow at the Autism and Obsessive Compulsive Spectrum Program at Montefiore Medical Center and the Albert Einstein College of Medicine. 

 

Use of Website Blog Commenting

Use of Website Blog Commenting

ADAA provides this Website blogs for the benefit of its members and the public. The content, view and opinions published in Blogs written by our personnel or contributors – or from links or posts on the Website from other sources - belong solely to their respective authors and do not necessarily reflect the views of ADAA, its members, management or employees. Any comments or opinions expressed are those of their respective contributors only. Please remember that the open and real-time nature of the comments posted to these venues makes it is impossible for ADAA to confirm the validity of any content posted, and though we reserve the right to review and edit or delete any such comment, we do not guarantee that we will monitor or review it. As such, we are not responsible for any messages posted or the consequences of following any advice offered within such posts. If you find any posts in these posts/comments to be offensive, inaccurate or objectionable, please contact us via email at [email protected] and reference the relevant content. If we determine that removal of a post or posts is necessary, we will make reasonable efforts to do so in a timely manner.

ADAA expressly disclaims responsibility for and liabilities resulting from, any information or communications from and between users of ADAA’s blog post commenting features. Users acknowledge and agree that they may be individually liable for anything they communicate using ADAA’s blogs, including but not limited to defamatory, discriminatory, false or unauthorized information. Users are cautioned that they are responsible for complying with the requirements of applicable copyright and trademark laws and regulations. By submitting a response, comment or content, you agree that such submission is non-confidential for all purposes. Any submission to this Website will be deemed and remain the property of ADAA.

The ADAA blogs are forums for individuals to share their opinions, experiences and thoughts related to mental illness. ADAA wants to ensure the integrity of this service and therefore, use of this service is limited to participants who agree to adhere to the following guidelines:

1. Refrain from transmitting any message, information, data, or text that is unlawful, threatening, abusive, harassing, defamatory, vulgar, obscene, that may be invasive of another 's privacy, hateful, or bashing communications - especially those aimed at gender, race, color, sexual orientation, national origin, religious views or disability.

Please note that there is a review process whereby all comments posted to blog posts and webinars are reviewed by ADAA staff to determine appropriateness before comments are posted. ADAA reserves the right to remove or edit a post containing offensive material as defined by ADAA.

ADAA reserves the right to remove or edit posts that contain explicit, obscene, offensive, or vulgar language. Similarly, posts that contain any graphic files will be removed immediately upon notice.

2. Refrain from posting or transmitting any unsolicited, promotional materials, "junk mail," "spam," "chain mail," "pyramid schemes" or any other form of solicitation. ADAA reserves the right to delete these posts immediately upon notice.

3. ADAA invites and encourages a healthy exchange of opinions. If you disagree with a participant 's post or opinion and wish to challenge it, do so with respect. The real objective of the ADAA blog post commenting function is to promote discussion and understanding, not to convince others that your opinion is "right." Name calling, insults, and personal attacks are not appropriate and will not be tolerated. ADAA will remove these posts immediately upon notice.

4. ADAA promotes privacy and encourages participants to keep personal information such as address and telephone number from being posted. Similarly, do not ask for personal information from other participants. Any comments that ask for telephone, address, e-mail, surveys and research studies will not be approved for posting.

5. Participants should be aware that the opinions, beliefs and statements on blog posts do not necessarily represent the opinions and beliefs of ADAA. Participants also agree that ADAA is not to be held liable for any loss or injury caused, in whole or in part, by sponsorship of blog post commenting. Participants also agree that ADAA reserves the right to report any suspicions of harm to self or others as evidenced by participant posts.

RESOURCES AND NEWS
Evidence-based Tips & Strategies from our Member Experts
RELATED ARTICLES
Block reference
TAKING ACTION
After viewing my art and story, I want others to understand that we are not alone in this and…

Advertisement